Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C‐reactive protein transgene
Open Access
- 3 June 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (6), 1602-1611
- https://doi.org/10.1002/art.11026
Abstract
Objective Human C-reactive protein (CRP) binds apoptotic cells and alters blood clearance of injected chromatin in mice. To test whether CRP participates in the pathogenesis of systemic lupus erythematosus (SLE), we examined disease development in lupus-prone (NZB × NZW)F1 (NZB/NZW) mice expressing a human CRP transgene (hCRPtg/BW). Methods Mortality was monitored, proteinuria was determined by dipstick, and serum levels of human CRP and anti–double-stranded DNA (anti-dsDNA) were determined by enzyme-linked immunosorbent assay in NZB/NZW and hCRPtg/BW mice. Thin sections of kidneys were analyzed by immunofluorescence microscopy to compare deposition of IgG, IgM, C3, and human CRP, and electron microscopy was used to reveal differences in ultrastructure. In situ hybridization was performed to detect human CRP messenger RNA expression. Results The hCRPtg/BW mice had less proteinuria and longer survival than NZB/NZW mice. They also had lower IgM and higher IgG anti-dsDNA titers than NZB/NZW mice, although the differences were transient and small. In hCRPtg/BW mice, accumulation of IgM and IgG in the renal glomeruli was delayed, reduced, and more mesangial than in NZB/NZW mice, while end-stage accumulation of IgG, IgM, and C3 in the renal cortex was prevented. There was less glomerular podocyte fusion, basement membrane thickening, mesangial cell proliferation, and occlusion of capillary lumens in hCRPtg/BW mice, but dense deposits in the mesangium were increased. With disease progression in hCRPtg/BW mice, there was little rise in the plasma CRP level, but CRP in the kidneys became increasingly apparent due to local, disease-independent, age-related expression of the transgene. Conclusion In hCRPtg/BW mice, CRP protects against SLE by increasing blood and mesangial clearance of immune complexes and by preventing their accumulation in the renal cortex.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI-42183)
This publication has 38 references indexed in Scilit:
- Advances in the Treatment of Lupus NephritisAnnual Review of Medicine, 2001
- GENETIC SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUSAnnual Review of Immunology, 1998
- Interrelationship between Autoepitope, DNA-Binding Domain, and CRP-Binding Domain on a Histone H1 MoleculeClinical Immunology and Immunopathology, 1993
- Definition of microsatellite size variants forTnfa andHsp70 in autoimmune and nonautoimmune mouse strainsImmunogenetics, 1992
- Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus.The Journal of Experimental Medicine, 1989
- Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.JCI Insight, 1988
- Amyloid P Component Binds to Keratin Bodies in Human Skin and to Isolated Keratin Filament Aggregates In VitroJournal of Investigative Dermatology, 1988
- C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.The Journal of Experimental Medicine, 1985
- C‐reactive protein levels in systemic lupus erythematosus: a classification criterion?Arthritis & Rheumatism, 1980
- Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of MiceNature, 1963